Bandres E - Search Results

1

Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients.

Romero RZ, Morales R, Garcia F, Huarriz M, Bandres E, De la Haba J, Gómez A, Aranda E, García-Foncillas J. Romero RZ, et al. Among authors: bandres e. Oncol Rep. 2006 Sep;16(3):497-503. Oncol Rep. 2006. PMID: 16865249

2

GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment.

Zárate R, González-Santigo S, de la Haba J, Bandres E, Morales R, Salgado J, Gómez A, Aranda E, García-Foncillas J. Zárate R, et al. Among authors: bandres e. Curr Drug Metab. 2007 Jun;8(5):481-6. doi: 10.2174/138920007780866780. Curr Drug Metab. 2007. PMID: 17584018

3

Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma.

Bandres E, Catalan V, Sola I, Honorato B, Cubedo E, Cordeu L, Andion E, Escalada A, Zarate R, Salgado E, Zabalegui N, García F, Garcia-Foncillas J. Bandres E, et al. Oncol Rep. 2004 Aug;12(2):287-92. Oncol Rep. 2004. PMID: 15254690

4

Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.

Bandrés E, Barricarte R, Cantero C, Honorato B, Malumbres R, Zárate R, Alcalde J, García-Foncillas J. Bandrés E, et al. Oral Oncol. 2007 Aug;43(7):713-9. doi: 10.1016/j.oraloncology.2006.09.002. Epub 2006 Nov 16. Oral Oncol. 2007. PMID: 17112774

5

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.

Bandrés E, Malumbres R, Cubedo E, Honorato B, Zarate R, Labarga A, Gabisu U, Sola JJ, García-Foncillas J. Bandrés E, et al. Oncol Rep. 2007 May;17(5):1089-94. Oncol Rep. 2007. PMID: 17390049 Free article.

6

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy.

Zárate RN, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Zárate RN, et al. Among authors: bandres e. World J Gastroenterol. 2006 Oct 7;12(37):6032-6. doi: 10.3748/wjg.v12.i37.6032. World J Gastroenterol. 2006. PMID: 17009404 Free PMC article.

7

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients.

Abajo A, Rodriguez J, Bitarte N, Zarate R, Boni V, Ponz M, Chopitea A, Bandres E, Garcia-Foncillas J. Abajo A, et al. Among authors: bandres e. Br J Cancer. 2010 Nov 9;103(10):1529-35. doi: 10.1038/sj.bjc.6605908. Epub 2010 Oct 12. Br J Cancer. 2010. PMID: 20940716 Free PMC article.

8

Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.

Bandres E, Andion E, Escalada A, Honorato B, Catalan V, Cubedo E, Cordeu L, Garcia F, Zarate R, Zabalegui N, Garcia-Foncillas J. Bandres E, et al. J Neurooncol. 2005 Jul;73(3):189-98. doi: 10.1007/s11060-004-5174-5. J Neurooncol. 2005. PMID: 15980968

9

Proteomic analysis in cancer research: potential application in clinical use.

García-Foncillas J, Bandrés E, Zárate R, Remírez N. García-Foncillas J, et al. Among authors: bandres e. Clin Transl Oncol. 2006 Apr;8(4):250-61. doi: 10.1007/BF02664935. Clin Transl Oncol. 2006. PMID: 16648100 Review.

10

Combining chemotherapy and targeted therapies in metastatic colorectal cancer.

Rodriguez J, Zarate R, Bandres E, Viudez A, Chopitea A, García-Foncillas J, Gil-Bazo I. Rodriguez J, et al. Among authors: bandres e. World J Gastroenterol. 2007 Nov 28;13(44):5867-76. doi: 10.3748/wjg.v13.i44.5867. World J Gastroenterol. 2007. PMID: 17990352 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters